(7S)-2-(3,5-dimethoxy-4-methylphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide
Structure Info
- Chemspace ID
- CSSB14823688795 (In-Stock Building Blocks)
- CAS
- 2283349-24-4
- MFCD
- MFCD30723103
- IUPAC Name
- (7S)-2-(3,5-dimethoxy-4-methylphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide
- Mol formula
- C24H31N5O4
- Mol weight
- 454 Da
- Catalog Number(s)
- AA02DHOL, AD265406, AG02DHRD, AR02DIGD, BD01954506, BN88577, BUP01055, EC02DJX5, HY-149051, M36520, ST02DJ85, T73381, TX02DIX1, Y4050696
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.11
- Heavy atoms count
- 33
- Rotatable bond count
- 6
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.458
- Polar surface area (Å)
- 112
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 2
![Chemical structure of (7S)-2-(3,5-dimethoxy-4-methylphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide (C24H31N5O4) - CSSB14823688795](/st/structure/200/53cd384a29206ecbabae85fb4e22652b/COc1cc%2528cc%2528OC%2529c1C%2529-c1nn2%255BC%2540%2540H%255D%2528CCNc2c1C%2528N%2529%253DO%2529C1CCN%2528CC1%2529C%2528%253DO%2529C%253DC.png "C24H31N5O4")
- Zoom the structure
- CSSB14823688795
Items Overall 27 items from 9 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Advanced ChemBlock Inc | 3 days | United States To: | 98 | 5 mg | 195.00 | |
| Advanced ChemBlock Inc | 3 days | United States To: | 98 | 25 mg | 475.00 | |
Description: BGB-8035; CAS: 2283349-24-4 | ||||||
| Advanced ChemBlocks CN | 3 days | China To: | 98 | 5 mg | 195.00 | |
| Advanced ChemBlocks CN | 3 days | China To: | 98 | 25 mg | 475.00 | |
Description: BGB-8035; CAS: 2283349-24-4 | ||||||
| 1st Scientific LLC | 7 days | United States To: | 90 | 1 mg | 144.10 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 5 mg | 238.70 | |
Description: BGB-8035; CAS: 2283349-24-4 | ||||||
| Angene International Limited | 10 days | China To: | 90 | 1 mg | 107.10 | |
| Angene International Limited | 10 days | China To: | 90 | 5 mg | 213.30 | |
| Angene International Limited | 10 days | China To: | 90 | 10 mg | 318.60 | |
| Angene International Limited | 10 days | China To: | 90 | 25 mg | 513.90 | |
| Angene International Limited | 10 days | China To: | 90 | 50 mg | 748.80 | |
Description: BGB-8035; CAS: 2283349-24-4 | ||||||
| A2B Chem | 12 days | United States To: | 97 | 1 mg | 80.50 | |
| A2B Chem | 12 days | United States To: | 97 | 5 mg | 161.00 | |
Description: BGB-8035; CAS: 2283349-24-4 | ||||||
| AA BLOCKS | 12 days | United States To: | 90 | 1 mg | 104.50 | |
| AA BLOCKS | 12 days | United States To: | 90 | 5 mg | 184.80 | |
Description: BGB-8035; CAS: 2283349-24-4 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 90 | 1 mg | 180.40 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 5 mg | 358.60 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 10 mg | 534.60 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 25 mg | 860.20 | |
| Accel Scientific, S.L. | 20 days | China To: | 90 | 50 mg | 1,255.10 | |
Description: BGB-8035; CAS: 2283349-24-4 | ||||||
| eNovation CN | 20 days | China To: | 95 | 1 mg | 230.00 | |
| eNovation CN | 20 days | China To: | 95 | 5 mg | 362.25 | |
| eNovation CN | 20 days | China To: | 95 | 10 mg | 494.50 | |
| eNovation CN | 20 days | China To: | 95 | 25 mg | 741.75 | |
| eNovation CN | 20 days | China To: | 95 | 50 mg | 1,058.00 | |
Description: BGB-8035; CAS: 2283349-24-4 | ||||||
| 10X CHEM | TBD | United States To: | 90 | 1 mg | 63.80 | |
| 10X CHEM | TBD | United States To: | 90 | 5 mg | 128.70 | |
Description: BGB-8035; CAS: 2283349-24-4 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of (7S)-2-(4-phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide - CSSB00134618176](/st/structure/200/b66f8b6dfba87e2501d26031797f6f8f/NC%2528%253DO%2529C1%253DC2NCC%255BC%2540%2540H%255D%2528C3CCN%2528CC3%2529C%2528%253DO%2529C%253DC%2529N2N%253DC1C1%253DCC%253DC%2528OC2%253DCC%253DCC%253DC2%2529C%253DC1.png)
![Chemical structure of 2-(4-phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide - CSSB00103150490](/st/structure/200/c7a14abae97c784a06b7be2d60b1d4d0/NC%2528%253DO%2529C1%253DC2NCCC%2528C3CCN%2528CC3%2529C%2528%253DO%2529C%253DC%2529N2N%253DC1C1%253DCC%253DC%2528OC2%253DCC%253DCC%253DC2%2529C%253DC1.png)
![Chemical structure of (7R)-2-(4-phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide - CSSB00134614544](/st/structure/200/364eace1cf01dfe982701ded8acf50de/NC%2528%253DO%2529C1%253DC2NCC%255BC%2540H%255D%2528C3CCN%2528CC3%2529C%2528%253DO%2529C%253DC%2529N2N%253DC1C1%253DCC%253DC%2528OC2%253DCC%253DCC%253DC2%2529C%253DC1.png)
![Chemical structure of 2-(4-phenoxyphenyl)-7-(piperidin-4-yl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide - CSSB02235353776](/st/structure/200/9c6d3c9d2ad652e6fc67649b3778282f/NC%2528%253DO%2529C1%253DC2NCCC%2528C3CCNCC3%2529N2N%253DC1C1%253DCC%253DC%2528OC2%253DCC%253DCC%253DC2%2529C%253DC1.png)
![Chemical structure of (7S)-2-(4-phenoxyphenyl)-7-(piperidin-4-yl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide - CSSB21241721508](/st/structure/200/f6cb9f77e82d83ec3402c51372988e1c/NC%2528%253DO%2529C1%253DC2NCC%255BC%2540%2540H%255D%2528C3CCNCC3%2529N2N%253DC1C1%253DCC%253DC%2528OC2%253DCC%253DCC%253DC2%2529C%253DC1.png)
![Chemical structure of N-{2-[1-(prop-2-enoyl)piperidin-4-yl]ethyl}acetamide - CSSB21043421677](/st/structure/200/91dc7570d29b1c3d1045ff98a16199c5/CC%2528%253DO%2529NCCC1CCN%2528CC1%2529C%2528%253DO%2529C%253DC.png)
![Chemical structure of 5-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-(prop-2-enoyl)piperidin-3-yl]-1H-pyrazole-4-carboxamide - CSSB00138413531](/st/structure/200/5bb038f7a8a1fbee861899ccbab8ce40/NC%2528%253DO%2529C1%253DC%2528N%2529N%2528N%253DC1C1%253DCC%253DC%2528OC2%253DCC%253DCC%253DC2%2529C%253DC1%2529%255BC%2540%2540H%255D1CCCN%2528C1%2529C%2528%253DO%2529C%253DC.png)
